Suppr超能文献

基础脑代谢率是挥发性麻醉药物脑血管扩张效力的关键决定因素。

Baseline Cerebral Metabolic Rate Is a Critical Determinant of the Cerebral Vasodilating Potency of Volatile Anesthetic Agents.

机构信息

From the Department of Anesthesiology, University of California, San Diego, California; and the Anesthesia Service, the Veterans Affairs San Diego Healthcare System, San Diego, California.

出版信息

Anesthesiology. 2018 Jul;129(1):187-189. doi: 10.1097/ALN.0000000000002219.

Abstract

A Comparison of the Direct Cerebral Vasodilating Potencies of Halothane and Isoflurane in the New Zealand White Rabbit. By Drummond JC, Todd MM, Scheller MS, and Shapiro HM. ANESTHESIOLOGY 1986; 65:462-7. Reprinted with permission.Halothane is commonly viewed as a more potent cerebral vasodilator than isoflurane. It was speculated that the lesser vasodilation caused by isoflurane might be the result of the greater reduction in cerebral metabolic rate (CMR) that it causes, and that the relative vasodilating potencies of halothane and isoflurane would be similar if the two agents were administered in a situation that precluded volatile-agent-induced depression of CMR. To test this hypothesis, cerebral blood flow (CBF) and the cerebral metabolic rate for oxygen (CMRO2) were measured in two groups of rabbits before and after the administration of 0.75 MAC halothane or isoflurane. One group received a background anesthetic of morphine and N2O, which resulted in an initial CMRO2 of 3.21 ± 0.17 (SEM) ml · 100 g · min; second group received a background anesthetic of high-dose pentobarbital, which resulted in an initial CMRO2 of 1.76 ± 0.16 ml · 100 g · min. In rabbits receiving a background of morphine sulfate/N2O, halothane resulted in a significantly greater CBF (65 ± 10 ml · 100 g · min) than did isoflurane (40 ± 5 ml · 100 g · min). Both agents caused a reduction in CMRO2, but CMRO2 was significantly less during isoflurane administration. By contrast, with a background of pentobarbital anesthesia, CBF increased by significant and similar amounts with both halothane and isoflurane. With halothane, CBF increased from 22 ± 2 ml · 100 g · min in the control stage to 39 ± 3, and with isoflurane from 24 ± to 38 ± 2 ml · 100 g · min. CMRO2 was not depressed further by either halothane or isoflurane. These results suggest that the relative effects of halothane and isoflurane on CBF are dependent on the CMR present prior to their administration. When the preexistent CMR is not markedly depressed, isoflurane decreases CMR and causes less cerebral vasodilation than does halothane. When initial CMR is depressed, halothane and isoflurane have similar vasodilating potencies.

摘要

氟烷与异氟烷直接扩张脑血管效能比较。作者:JC·德拉蒙德、MM·托德、MS·谢勒和 HM·夏皮罗。《麻醉学》1986 年;65:462-7. 经许可重印。氟烷通常被认为是一种比异氟烷更强的脑血管扩张剂。人们推测,异氟烷引起的血管舒张作用较小可能是由于它引起的脑代谢率(CMR)降低所致,如果两种药物在一种可以防止挥发性药物引起 CMR 降低的情况下使用,那么氟烷和异氟烷的相对扩张血管效能应该是相似的。为了验证这一假设,在两组新西兰白兔中,在给予 0.75 MAC 氟烷或异氟烷前后测量脑血流(CBF)和脑氧代谢率(CMRO2)。一组接受吗啡和 N2O 的背景麻醉,导致初始 CMRO2 为 3.21 ± 0.17(SEM)ml·100g·min;第二组接受高剂量戊巴比妥的背景麻醉,导致初始 CMRO2 为 1.76 ± 0.16 ml·100g·min。在接受硫酸吗啡/N2O 背景麻醉的兔子中,氟烷导致的 CBF(65 ± 10 ml·100g·min)明显大于异氟烷(40 ± 5 ml·100g·min)。两种药物都导致 CMRO2 降低,但异氟烷时 CMRO2 降低更明显。相比之下,在戊巴比妥麻醉的背景下,氟烷和异氟烷均导致 CBF 显著增加。氟烷时,CBF 从对照阶段的 22 ± 2 ml·100g·min 增加到 39 ± 3,异氟烷时从 24 ± 增加到 38 ± 2 ml·100g·min。氟烷和异氟烷均未进一步降低 CMRO2。这些结果表明,氟烷和异氟烷对 CBF 的相对影响取决于给药前的 CMR。当预先存在的 CMR 没有明显降低时,异氟烷降低 CMR,引起的脑血管扩张作用小于氟烷。当初始 CMR 降低时,氟烷和异氟烷具有相似的扩张血管效能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验